Cancer Conference Update
Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:37:38
- Mas informaciones
Informações:
Sinopsis
Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York City discusses available and emerging data with oral SERDs for patients with ER-positive metastatic breast cancer. CME information and select publications here.
